Biotech Netzwerk Sachsen

The 2012 World Gene Therapy Congress Europe is the senior director-level conference that tackles all the key scientific and technical issues facing the gene therapy industry and where decision-makers from the complete Gene Therapy value chain meet to learn and plan for the future.

It’s an exclusive gathering of the cutting edge companies and leading solution providers in the Gene Therapy industry.It is a place where innovation is showcased, solutions are found and learning is done.

Biomarker professionals will gather together to answer the all important question- how can we get biomarkers to add value? How do you develop new medicines which demonstrate real value through predictable outcomes in targeted patient groups?

The event is a two day strategic conference tackling these questions and providing participants with a thorough review of the use of biomarkers, their effectiveness and their potential to transform R & D.

Capturing Innovation in China™: ChinaBio® Partnering Forum is the premier life science partnering event in China. To be held on May 23–24, 2012 in Suzhou, the fourth edition of the event will gather biotech and pharma leaders from around the world along with hundreds of China-based developers of novel technologies for two days of productive partnering. In addition, the successful Innovation Showcase track will feature top researchers from leading institutes and universities throughout China. ChinaBio® Partnering Forum 2011 attracted 644 attendees from 370 companies who participated in 807 one-to-one meetings facilitated by partneringONE®, making it the largest partnering conference in China.

The biggest and the most important international event for biotechnology in the region of Central Europe!

Since the year 2000 the main goal of BioForum is to create business networking within Central Europe to attract well-established US and Western Europe biobusiness. It is an event supporting technology transfer from life sciences (biotechnology, biochemistry, molecular biology, etc.) to areas such as bioeconomy, health, drugs and food production, cosmetics and environment. BioForum visitors are given a unique possibility to dive into a sea of valuable, applicable R&D projects gathered in one place at the same time.

The European Life Science Awards aim to publically recognise the efforts and contributions of organisations and individuals in the life science industry.

Our mission is to identify and reward organisations and individuals who have demonstrated an unparalleled ability of excellence, and who will be the future stars of the biopharma industry.

The 2012 Awards ceremony itself will be held on May 29th 2012 at The Radisson Blu Hotel in Hamburg and precedes the European Lab Automation congress, which take place at the adjoining conference centre-CCH on May 30th – 31st.

EuroMedtech™ 2012 brings together the myriad sectors of the medtech industry, creating a forum dedicated to forging partnerships between large companies and innovators, public and private companies and investors, institutes and industry. EuroMedtech caters to companies involved in all parts of the advanced medical technology industry, from those serving mainline therapeutic categories such as orthopedics and cardiovascular, through diagnostics, imaging and eHealth, to those involved in platform technologies such as biomaterials and regenerative medicine. Also attending are companies serving the industry, such as manufacturers, law firms, CROs and distributors.

The event features EBD Group’s sophisticated, web-based partnering system, partneringONE®, the life science’s leading conference networking solution that enables delegates to efficiently mine a large pool of potential partners and pre-arrange private one-to-one meetings.
EuroMedtech also features 15-minute presentations of medical technology innovations by start-ups and established firms, insightful panel discussions on industry developments and business development trends, and opportunities for informal networking.

We invite you to join us in Grenoble for Europe’s most intensely productive advanced medical technology event of the year.

For more information: www.ebdgroup.com/emt

We will once again be showcasing the best of UK and European biotechs in a one day format. Some 50-60 European and UK biotech companies will be presenting and are looking for partners, investment or services. Our audience will comprise 250 – 300 delegates from the pharma, biotech, investor, CRO and service sectors. Industry keynotes will set the tone for the day and partnering will take place all day as well as informal networking

More information …

Bio-IT World Asia 2012 will bring together, life sciences, pharmaceutical, informatics and IT professionals from all over Asia and the rest of the world to one unique location. The Event provides the perfect venue to share information and discuss enabling technologies that are driving biomedical research and the drug development process.

More Information ….

The Annual World Theranostics Congress Europe is the industry's dedicated scientific and commercial congress for senior pharmaceutical, biotech and CD stakeholders keen to develop capabilities in this massively growing field. In 2011 the event produced a high calibre attendance from the World's leading Pharma and CD developers. In 2012 expect a larger and more diverse value chain as the industry spreads its wings.

Die Nanofair ist Europas größter Branchentreff im Bereich Nanotechnologie. Seit 2002 treffen sich in Dresden internationale Experten aus Wissenschaft, angewandter Forschung und Wirtschaft.

Die Konferenz wird vom Fraunhofer-Institut für Werkstoff- und Strahltechnik (IWS) in enger Kooperation mit den Mitgliedern des DRESDEN-concept sowie der Landeshauptstadt Dresden organisiert. In dieser Konstellation ist eine enge Verbindung zum aktiven Geschehen in Unternehmen und Forschungseinrichtungen gewährleistet

ACHEMA is the world forum of the process industry and the trend-setting technology summit for chemical engineering, environmental protection and biotechnology. The 30th ACHEMA will again be the leading international meeting point for decision-makers and experts from all related industries:

The BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech, offers key networking and partnering opportunities, and provides insights and inspiration on the major trends affecting the industry.

Die PerMediCon fokussiert sich ausschließlich auf das Thema der personalisierten Medizin. Dabei bietet die interdisziplinäre Veranstaltung ein breites Themenspektrum mit renommierten Vertretern aus den Bereichen Wissenschaft, Industrie, Ärzteschaft, Behörden, Politik, Investoren und Patientenorganisationen.

Jeder einzelne Programmpunkt innerhalb der PerMediCon wird aus mindestens drei dieser Perspektiven heraus diskutiert und flankierend durch politische, ökonomische, ethische oder regulatorische Rahmenbedingung ergänzt.

XXVII Congress of the International Society for the Advancement of Cytometry

The 24th Congress is designed for physicians, surgeons, scientists and organ procurement personnel, who are interested in clinical and research aspects of solid organ, cell and tissue transplantation. The program is developed to encourage the exchange of new scientific and clinical information, and support an interchange of opinions regarding care and management issues, as well as socioeconomic, ethical and regulatory issues relevant to transplantation.

In addition to the classical types of scientific sessions including plenary sessions, symposia, workshops and poster presentations, we will also offer new types of scientific sessions within the Forum Futurum focusing on Intensive Care, Imaging and Tailored Pharmacotherapy. All of this is designed to develop a highly interactive forum to discuss cutting-edge science in our field.

More information …

The Next Generation Dx Summit (Enabling Point-of-Care Diagnostics, Emerging Molecular Markers of Cancer, Molecular Diagnostics for Infectious Disease, Companion Diagnostics, Commercialization of Molecular Diagnostics, Translating Proteomics & Metabolomics into the Clinical Laboratory, and Mass Spectrometry in Clinical Diagnostics) is designed to bring together all of the major players in the evolving areas of diagnostics.  This year, we are introducing proteomic and metabolomic technologies that are making their way into clinical diagnostics. We have assembled an impressive faculty of speakers from industry, government, and leading academic institutions. This meeting will showcase improvements in technology research and development with an emphasis towards application to the clinical laboratory and commercialization. Plan to hear what the key players in the industry are saying about what to expect for the rapid changes ahead.

BioPharma Convention Australasia brings together pharmas, biotechs, government and R&D community to discuss how to develop winning business models, access funding and new markets, find new partnerships and source for new solutions.

BioPharma Convention Australasia is an exciting concept- eight modules over two days, 1:1 clinics and whitepaper rooms. Delegates can design their own event, transitioning between the modules for maximum value.

Profile your solutions and services at BioPharma Convention Australasia where senior decision makers from pharmas, biotechs, R&D community gather.

The 13th Annual Business of Biosimilars & Generic Drugs is the world's largest development and commercialization event for the follow-on biopharmaceutical industry, bringing drug development and market access executives the tools to compete and maximize pipeline profitability in today's global competitive environment.

more information …

World Biosimilars Congress Europe 2012 is positioned as Europe’s most innovative drug development and Biosimilars conference, it is a global knowledge experience, business meeting and access vehicle to your marketplace.

World Biosimilars Congress Europe is where decision-makers from large big pharmaceutical companies, the key mid cap biotechs, major generic and regional generic companies, SME biotechs, government officials, investment professionals and the wider contract service community meet to learn and plan for the future of this growing industry.

more information …

The 2012 World Drug Repositioning Congress is Europe’s first commercially orientated conference that provides key technical and strategic solutions to challenges faced when adopting drug repositioning into your R&D efforts.

The World Drug Repositioning Congress Europe is where decision-makers from the wider biopharmaceutical industry and service providers meet to determine best practice for drug repositioning and learn how to successfully bridge the innovation deficit through drug repositioning.

Where partnerships start – Beginning its fifth year as an industry event, BioPharm America creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.  It is a pure partnering event focused on one-to-one meetings driven by the partneringONE® software platform that schedules meetings and provides each participant with a dynamic personalized agenda and regular alerts for further meeting opportunities.

For information about the BioPharm America 2012 program and registration information, please register your email address for regular updates from EBD Group at update@ebdgroup.com.

Contact:
Christina Hundschell
EBD Group, Inc.
2032 Corte del Nogal, Suite 120
Carlsbad, CA 92011, USA
T: +1 760 930 0500
F: +1 760 930 0520
chundschell@ebdgroup.com

Website:
www.ebdgroup.com/bpa

Industry:
Biotech

Intended For:
Top international executives from:
 Established and emerging biotech companies
 Pharmaceutical companies
 Institutional financial firms
 Private investors including venture capital and private equity firms

NEURODIAB ist eine Arbeitsgruppe der European Association for the Study of Diabetes (EASD), die sich auf klinische und experimentelle Aspekte der diabetischen Neuropathie konzentriert.
Primäres Ziel ist es, den Fortschritt des Wissens über alle Aspekte der diabetischen Neuropathie durch aktive Zusammenarbeit zwischen interessierten Diabetologen und anderen Spezialisten wie Neurologen, Neurophysiologen, Urologen und Gastroenterologen zu fördern.

Das wissenschaftliche Programm enthält Original-Forschungsarbeiten und wird wichtige neue Informationen zu Diabetes-induzierten Erkrankungen des peripheren und zentralen Nervensystems präsentieren. Die Veranstaltung bietet Ärzten und Grundlagenforschern Gelegenheit zur Präsentation und Diskussion neuer Ideen zur Schadensursache, Beurteilung und Behandlung der diabetischen Neuropathie. Die Organisatoren erwarten wie in den vergangenen Jahren ca. 230 Teilnehmer und möchten auch Unternehmen und Institutionen einladen, diese Präsentationsplattform zu nutzen.

Mehr

The Meeting will be open in all aspects of tissue repair and regeneration. Special emphasis will be given in recent advances of molecular biology and biotechnology, for the in depth understanding of the pathophysiological mechanisms and for potential clinical applications.

more information …

Main topics: Stem Cells and Clinical Applications

More Information as soon as possible

The 18th annual BIO-Europe® event will be the largest biotechnology partnering conference held in Europe. Over 3,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.

The Symposium wants to view the topic of "Stem Cells and Clinical Applications".

Stem cells offer many opportunities for biomedical applications. More and more stem cell research is becoming relevant for clinical applications. We want to invite you to present your scientific work and also to meet renowned keynote speakers as well as other scientists from the exciting field of stem cell research. This symposium offers you the opportunity to hear about and discuss new scientific developments, encounter new people, and meet old friends and colleagues. With the industrial exhibition you will surely find a good platform to communicate your expectations and needs for your research with business partners.

further  information …

Biopharma India Convention 2012 is the region’s leading industry event where biopharmaceutical stakeholders across India and beyond leverage on to identify innovation and partnership opportunities as well as best business and operationally effective practices in India’s biopharmaceutical industry.

This is the only biopharmaceutical-focused event in India of its kind. Within 3 days, expect to network with more than 300 industrial stakeholders and players at one event to develop your business development strategies in India.

More information ….

The importance of the field of Regenerative Medicine is continuously growing. It is even becoming more visible to the public eye. That is why I am very happy that we have fulfilled our duty to stimulate a communication platform that pushes new ideas, partnerships, and synergies in our scientific processes.

In the name of the organizers of the Fraunhofer Institute for Cell Therapy and Immunology and of the Translational Centre for Regenerative Medicine Leipzig I am proud to announce the upcoming World Conference on Regenerative Medicine in Leipzig on October 23 – 25, 2013. Please save the date in your calendar.

more information as soon as possible.